(RTTNews) - Yuhan Corp. (000100.KS, 000105.KS), a South Korean pharmaceutical and chemical manufacturing company, on Wednesday reported a decline in net income despite higher sales in the third quarter of 2026 compared with the previous year.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.